Market Place
Sourcing Support
Metrion Launches Nav1.9 HTS Assay for Pain Drug Research
28 Apr 2025 //
BUSINESSWIRE
Metrion Biosciences appoints Lee Patterson as CEO
25 Nov 2024 //
BUSINESSWIRE
Metrion Biosciences Appoints Dr Chris Mathes as Chief Commercial Officer
23 Jul 2024 //
BUSINESSWIRE
Metrion Enhances Screening With Enamine Libraries Access
11 Apr 2024 //
BUSINESSWIRE
Metrion Biosciences Closes £3.7m New Equity Financing
20 Dec 2023 //
BUSINESSWIRE
Metrion Announces Launch of GLP hERG Screening Service
01 Aug 2023 //
BUSINESSWIRE
Metrion Biosciences Launches GLP hERG Screening Service
01 Aug 2023 //
CONTRACT PHARMA
Metrion Biosciences Expands Senior Leadership Team
06 Jul 2023 //
CONTRACT PHARMA
Metrion Appoints Dr Robert Kirby as COO and Dr Edward Stevens as CSO
06 Jul 2023 //
BUSINESSWIRE
Metrion & KCNC1 Foundation Collaborate on Development of Ion Channel Modulators
07 Dec 2022 //
BUSINESSWIRE
Metrion Bio Appoints Dr Benedetta Montagnini as Head of EU Business Development
08 Jun 2022 //
BUSINESSWIRE
Metrion, Bioqube Collaborate on Venture Creation Project for Autoimmune Diseases
16 Dec 2021 //
BUSINESSWIRE
Metrion Biosciences Enhances Ion Channel Drug Discovery Service Capabilities
07 Dec 2021 //
CONTRACTPHARMA
Metrion Biosciences Appoints Dr. Roy Curtis as VP U.S. Commercial Operations
30 Nov 2021 //
CONTRACTPHARMA
Metrion Biosciences Expands into New Cambridge HQ
22 Sep 2021 //
CONTRACTPHARMA
Metrion Biosciences appoints Nick Foster as Chief Commercial Officer
26 Jul 2021 //
BUSINESSWIRE
Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer
26 Jul 2021 //
CONTRACT PHARMA
Metrion Biosciences Closes £2.7m New Equity Financing
05 Apr 2020 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.